Camila (Norethindrone) - Summary

CAMILA SUMMARY

Camila™ (norethindrone tablets, USP 0.35 mg)

Each light pink norethindrone tablet provides a continuous oral contraceptive regimen of 0.35 mg norethindrone daily.

1. Indications:

Progestin-only oral contraceptives are indicated for the prevention of pregnancy.

2. Efficacy:

If used perfectly, the first-year failure rate for progestin-only oral contraceptives is 0.5%. However, the typical failure rate is estimated to be closer to 5%, due to late or omitted pills.

See all Camila indications & dosage >>

CAMILA NEWS HIGHLIGHTS

Media Articles Related to Camila (Norethindrone)

UPC Student Achieves Control Of Collagen Nanofibers To Manufacture Synthetic Knee Cartilage
Source: Bones / Orthopaedics News From Medical News Today [2008.11.15]

more >>

Published Studies Related to Camila (Norethindrone)

Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women. [2008.09]

Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study. [2007.09]

Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging. [2006.11]

Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials. [2006.06]

Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects. [2005.11]

more >>

Clinical Trials Related to Camila (Norethindrone)

Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg) [Recruiting]

TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women. [Recruiting]

Study of Safety and Efficacy of an Oral Contraceptive [Active, not recruiting]

Efficacy of Tibolone Versus Transdermal E2/NETA on Sexual Function in Naturally Postmenopausal Women [Completed]

The Effect of the Mini-Pill on Blood Factors in Women at Increased Risk for Forming Blood Clots [Recruiting]

more >>